Institutional Ownership
Indivior Pharmaceuticals Inc
CUSIP 45579U109COMINDVQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
281
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 18.54M | $565.17M |
| 2 | Oaktree Capital Management LP | 6.98M | $212.88M |
| 3 | State Street Corp | 4.90M | $149.47M |
| 4 | Two Seas Capital LP | 4.75M | $144.67M |
| 5 | Millennium Management LLC | 4.60M | $140.07M |
| 6 | Fuller & Thaler Asset Management, Inc. | 4.53M | $138.06M |
| 7 | Madison Avenue Partners, LP | 4.32M | $131.53M |
| 8 | Citadel Advisors LLC | 3.57M | $108.94M |
| 9 | Morgan Stanley | 3.51M | $106.86M |
| 10 | Deerfield Management Company, L.P. | 3.10M | $94.42M |